Lund-Hansen Torben - Insider Non-Derivative Transactions at Y-mAbs Therapeutics, Inc. (YMAB) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 28, 2024, Lund-Hansen Torben's relationship to Y-mAbs Therapeutics, Inc. (YMAB) is Officer (SVP & CHIEF TECHNICAL OFFICER), and currently has 85,600 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other YMAB insiders.
Data Source: SEC.
Lund-Hansen Torben - Insider Non-Derivative Transactions of YMAB Common Stock
Lund-Hansen Torben - Insider Non-Derivative Transactions at YMAB
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 29, 2024 | Sell -- (Common Stock) | 50000 | 15.37 | 35600 |
| Aug 29, 2024 | M -- (Common Stock) | 50000 | 4.38 | 85600 |
| Jan 19, 2024 | Acquisition -- (Common Stock) | 17800 | 0 | 35600 |
| Jan 18, 2023 | Acquisition -- (Common Stock) | 17800 | 0 | 17800 |